Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
The International Journal of Health Planning and Management|November 29, 2019
Modelling the neonatal system: A joint analysis of length of stay and patient pathwaysShola Adeyemi, Eren DemirComputer Methods and Programs in Biomedicine|May 27, 2011
Profiling hospitals based on emergency readmission: a multilevel transition modelling approachEren Demir, Thierry Chaussalet, Shola Adeyemi, et al.The International Journal of Health Planning and Management|June 28, 2021
HIV-MSS: A user-friendly management support system for better planning of HIV care servicesEren Demir, Shola Adeyemi, Andre Pascal Kengne, et al.Archives of Disease in Childhood. Fetal and Neonatal Edition|May 15, 2010
Towards effective capacity planning in a perinatal network centreMd Asaduzzaman, Thierry J Chaussalet, Shola Adeyemi, et al.The Pan African Medical Journal|December 31, 2021
Impact of pre-exposure and post-exposure prophylaxes prevention programme on HIV burden and services in a low-resource setting: a simulation modelling approachAdekunle Olatayo Adeoti, Eren Demir, Shola Adeyemi, et al.European Journal of Pain (London, England)|August 17, 2022
Efficacy and safety of co-crystal of tramadol-celecoxib (CTC) in acute moderate-to-severe pain after abdominal hysterectomy: A randomized, double-blind, phase 3 trial (STARDOM2)Richard Langford, Adelaida Morte, Mariano Sust, et al.Advances in Therapy|January 6, 2024
Co-crystal of Tramadol-Celecoxib Versus Tramadol or Placebo for Acute Moderate-to-Severe Pain After Oral Surgery: Randomized, Double-Blind, Phase 3 Trial (STARDOM1)Richard Langford, Esther M Pogatzki-Zahn, Adelaida Morte, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 2026
Efficacy and Tolerability of Zenocutuzumab in Advanced <i>NRG1</i> Fusion-Positive Cholangiocarcinoma: Results From the eNRGy Phase II TrialJames M Cleary, Christoph Springfeld, Dirk Arnold, et al.The New England Journal of Medicine|February 5, 2025
Efficacy of Zenocutuzumab in <i>NRG1</i> Fusion-Positive CancerAlison M Schram, Koichi Goto, Dong-Wan Kim, et al.Pageof 1